Glaucoma News Briefs
- FDA Approves Hydrus MIGS Device
- FDA Clears IOP Measuring Device
- Santen Begins Phase 3 Trials for Glaucoma Agonist
- Nidek Launches New Type of Gonioscope
- Contact Lens Changes Color As It Releases Drugs
- iStent Effective in Severe Glaucoma
- Metrovision Launches Perimeter in US Market
- Oculus Introduces Smartfield Perimeter
- Bariatric Surgery Can Lower IOP
- Xelpros Approved as BAK-Free Latanoprost
- European Regulators Accept Rhopressa Application
- Optometrists’ Adherence to AAO Glaucoma Guidelines
- Immune Cells May Play Role in Glaucoma Vision Loss
- MIGS Drives Growth in Glaucoma Device Market
- Aflibercept Reduces IOP in Neovascular Glaucoma Study
- Topcon Gets Clearance for Laser Software
Featured Articles in the Current Issue
Essential to practice or still a research tool?
In conjunction with clinical exams, this test can provide insights that better direct glaucoma treatment.
The when, why, how, and who of screening for glaucoma.
Considerations for learning and incorporating MIGS.
Departments and Columns
The FDA and industry collaborate to ensure safety.
A MIGS procedure with an excellent safety profile.
The answer is not as simple as you might think.
The rigorously studied device has impressive efficacy and safety records.